Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
gp120 is a glycoprotein exposed on the surface of the HIV envelope, essential for virus entry into host cells. It binds to CD4 receptors and chemokine co-receptors CCR5 or CXCR4 on host cells, initiating the membrane fusion process. The extensive glycan shield and sequence variability contribute to immune evasion, making it a challenging target for therapeutic intervention.
Blocking viral entry by interfering with gp120 binding to CD4 or co-receptors (CCR5/CXCR4)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV Envelope Glycoprotein gp120 (gp120).